Eastwood Bio-Medical Canada Inc Cash Flow Conversion Efficiency

Latest as of April 2026: -0.001x

Eastwood Bio-Medical Canada Inc cash flow conversion efficiency. Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) has a cash flow conversion efficiency ratio of -0.001x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$2.26K ≈ $1.63K USD) by net assets (CA$-1.72 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eastwood Bio-Medical Canada Inc (2013–2025)

Cash flow conversion efficiency of Eastwood Bio-Medical Canada Inc from 2013 to 2025. This chart illustrates how Eastwood Bio-Medical Canada Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Eastwood Bio-Medical Canada Inc stock price today for real-time trading data and today's change.

Eastwood Bio-Medical Canada Inc Cash Flow Conversion Ratio Explained

Eastwood Bio-Medical Canada Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eastwood Bio-Medical Canada Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their cash flow conversion efficiency. Also see how much is Eastwood Bio-Medical Canada Inc worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Fabryki Mebli Forte S.A. WAR:FTE	0.029x
AVer Information Inc TW:3669	0.019x
Medtecs International Corporation Ltd DRC TW:9103	0.027x
CURATIS N AG SW:CURN	-0.024x
Immobile WAR:GKI	0.215x
Data Communications Management Ltd TO:DCM	0.347x
Agrify Corp NASDAQ:AGFY	-0.459x
Sao Ta Foods JSC VN:FMC	0.089x

Annual Cash Flow Conversion Efficiency for Eastwood Bio-Medical Canada Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Eastwood Bio-Medical Canada Inc from 2013 to 2025. Review cash generation quality of Eastwood Bio-Medical Canada Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-10-31	CA$-1.63 Million ≈ $-1.18 Million	CA$19.30K ≈ $13.96K	-0.012x	-200.95%
2024-10-31	CA$-1.30 Million ≈ $-937.99K	CA$-15.22K ≈ $-11.01K	0.012x	-41.57%
2023-10-31	CA$-840.80K ≈ $-608.22K	CA$-16.89K ≈ $-12.22K	0.020x	+37.61%
2022-10-31	CA$-294.20K ≈ $-212.82K	CA$-4.29K ≈ $-3.11K	0.015x	-98.19%
2021-10-31	CA$-144.32K ≈ $-104.40K	CA$-116.21K ≈ $-84.07K	0.805x	+168.15%
2020-10-31	CA$459.27K ≈ $332.23K	CA$-542.69K ≈ $-392.58K	-1.182x	-770.13%
2019-10-31	CA$1.31 Million ≈ $948.87K	CA$-178.13K ≈ $-128.86K	-0.136x	+43.59%
2018-10-31	CA$1.89 Million ≈ $1.37 Million	CA$-454.79K ≈ $-328.99K	-0.241x	-87.18%
2017-10-31	CA$2.76 Million ≈ $2.00 Million	CA$-355.28K ≈ $-257.00K	-0.129x	-34.57%
2016-10-31	CA$3.21 Million ≈ $2.32 Million	CA$-306.58K ≈ $-221.77K	-0.096x	-31.67%
2015-10-31	CA$3.73 Million ≈ $2.70 Million	CA$-270.51K ≈ $-195.68K	-0.073x	-118.34%
2014-10-31	CA$3.99 Million ≈ $2.88 Million	CA$1.58 Million ≈ $1.14 Million	0.396x	-67.40%
2013-10-31	CA$-208.29K ≈ $-150.68K	CA$-252.88K ≈ $-182.93K	1.214x	--

About Eastwood Bio-Medical Canada Inc

V:EBM Canada Biotechnology

Market Cap

$94.68 Million

CA$130.88 Million CAD

Market Cap Rank

#19433 Global

#647 in Canada

Share Price

CA$1.90

Change (1 day)

-2.56%

52-Week Range

CA$0.50 - CA$2.00

All Time High

CA$8.48